Ledger.Open graph →
SEC Form D · filed November 17, 2015

Amylyx Pharmaceuticals, Inc

Offering
$1.6M
Sold
$1.4M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (15)

Stephen D. Chubb · Cambridge, MADirectorPeter B. Finn · Boston, MAExecJustin Klee · Cambridge, MADirectorJoshua Cohen · Cambridge, MAExec · DirectorGeorge M. Milne, Ph.D · Cambridge, MADirectorChristopher F. Linneman · Boston, MAExec · DirectorEric M. Siegal · CHICAGO, ILExecJames F. Kellogg Iii · Boston, MADirectorVikram F. Punwani · Boston, MADirectorJonathan J. Desimone · Boston, MADirectorDaniel M. Rosenbloom · CHICAGO, ILExecMikhail Plam · Louisville, CODirectorDavid C. Barker · Louisville, COExec · DirectorVincent P. Mihalik · Louisville, CODirectorNiles C. Utlaut · Louisville, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗